IBRN holdings — iShares Neuroscience and Healthcare ETF
iShares Neuroscience and Healthcare ETF (IBRN) held 78 positions with net assets of $5.49M as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 56.2% of the fund, led by BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares, DNTH, XENE.
IBRN top holdings
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 14.64% ($803K)
- DNTH Dianthus Therapeutics Inc — 5.34% ($293K)
- XENE Xenon Pharmaceuticals Inc — 4.87% ($267K)
- PRAX Praxis Precision Medicines Inc — 4.87% ($267K)
- ACAD ACADIA PHARMACEUTICALS INC. — 4.69% ($257K)
- ARWR ARROWHEAD PHARMACEUTICALS, INC. — 4.65% ($255K)
- ALKS ALKERMES PUBLIC LIMITED COMPANY — 4.60% ($252K)
- SRRK Scholar Rock Holding Corp — 4.29% ($235K)
- BIIB BIOGEN INC. — 4.18% ($229K)
- NBIX NEUROCRINE BIOSCIENCES, INC. — 4.09% ($224K)
- ARGX argenx SE — 3.86% ($212K)
- PTCT PTC THERAPEUTICS, INC. — 3.85% ($211K)
- AXSM AXSOME THERAPEUTICS, INC. — 3.77% ($207K)
- DNLI Denali Therapeutics Inc — 3.67% ($201K)
- DYN Dyne Therapeutics, Inc — 3.56% ($195K)
- EWTX Edgewise Therapeutics Inc — 3.23% ($177K)
- SUPN SUPERNUS PHARMACEUTICALS, INC. — 2.61% ($143K)
- AXGN AxoGen, Inc. — 2.34% ($128K)
- SK Biopharmaceuticals Co Ltd — 2.30% ($126K)
- H. LUNDBECK A/S — 1.84% ($101K)
- BHVN Biohaven Ltd — 1.82% ($99.6K)
- SRPT SAREPTA THERAPEUTICS, INC. — 1.61% ($88.5K)
- BioArctic AB — 1.56% ($85.6K)
- TSHA Taysha Gene Therapies Inc — 1.50% ($82.0K)
- Neuren Pharmaceuticals Ltd — 1.48% ($81.1K)
What are IBRN's top 10 holdings?
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares (14.6%), DNTH (5.3%), XENE (4.9%), PRAX (4.9%), ACAD (4.7%), ARWR (4.7%), ALKS (4.6%), SRRK (4.3%), BIIB (4.2%), NBIX (4.1%).
How many stocks are in IBRN?
iShares Neuroscience and Healthcare ETF reported 78 holdings as of July 31, 2026.